Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis'

Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis

0.75

Claim your AMA PRA Category 1 Credits or CNE Contact Hours

This course is available for logged in users only. Please login or register to take the course.

Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...

Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in ...

Beyond Symptom Control: Targeting BAFF/APRIL Pathways in Generalized Myasthenia Gravis